Dong-Ping Sang1, Ru-Jun Li2, Qing Lan2. 1. 1] Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou 215004, China [2] Department of Neurosurgery, Changshu Traditional Chinese Medical Hospital, Changshu 215500, China. 2. Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Abstract
AIM: Quercetin is an effective Hsp27 inhibitor and has been reported to facilitate tumor cell apoptosis. The aim of this study was to investigate whether quercetin could sensitize human glioblastoma cells to temozolomide (TMZ) in vitro. METHODS: Both U251 and U87 human glioblastoma cells were treated with quercetin and/or TMZ for 48 h. Cell viability was detected using the MTT assay. Cell apoptosis was analyzed with caspase-3 activity kits and flow cytometry. Hsp27 expression and phosphorylation were examined using Western blot analysis. RNA interference using Hsp27 siRNA oligos was performed to knock down the gene expression of Hsp27. RESULTS: TMZ (200 or 400 μmol/L) alone effectively inhibited the viability of U251 and U87 cells. When combined with quercetin (30 μmol/L), TMZ (100 μmol/L) significantly inhibited the cell viability, and the inhibition of TMZ (200 and 400 μmol/L) was enhanced. TMZ or quercetin anole did not affect caspase-3 activity and cell apoptosis, while TMZ combined with quercetin significantly increased caspase-3 activity and induced cell apoptosis. TMZ anole significantly increased Hsp27 phosphorylation in U251 and U87 cells, while quercetin or Hsp27 siRNA oligos combined with TMZ attenuated TMZ-induced Hsp27 phosphorylation and significantly inhibited Hsp27 expression. CONCLUSION: Combined treatment with TMZ and quercetin efficiently suppressed human glioblastoma cell survival in vitro.
AIM: Quercetin is an effective Hsp27 inhibitor and has been reported to facilitate tumor cell apoptosis. The aim of this study was to investigate whether quercetin could sensitize humanglioblastoma cells to temozolomide (TMZ) in vitro. METHODS: Both U251 and U87 humanglioblastoma cells were treated with quercetin and/or TMZ for 48 h. Cell viability was detected using the MTT assay. Cell apoptosis was analyzed with caspase-3 activity kits and flow cytometry. Hsp27 expression and phosphorylation were examined using Western blot analysis. RNA interference using Hsp27 siRNA oligos was performed to knock down the gene expression of Hsp27. RESULTS:TMZ (200 or 400 μmol/L) alone effectively inhibited the viability of U251 and U87 cells. When combined with quercetin (30 μmol/L), TMZ (100 μmol/L) significantly inhibited the cell viability, and the inhibition of TMZ (200 and 400 μmol/L) was enhanced. TMZ or quercetin anole did not affect caspase-3 activity and cell apoptosis, while TMZ combined with quercetin significantly increased caspase-3 activity and induced cell apoptosis. TMZ anole significantly increased Hsp27 phosphorylation in U251 and U87 cells, while quercetin or Hsp27 siRNA oligos combined with TMZ attenuated TMZ-induced Hsp27 phosphorylation and significantly inhibited Hsp27 expression. CONCLUSION: Combined treatment with TMZ and quercetin efficiently suppressed humanglioblastoma cell survival in vitro.
Authors: Paul R Gielen; Qurratulain Aftab; Noreen Ma; Vincent C Chen; Xiaoting Hong; Shannon Lozinsky; Christian C Naus; Wun Chey Sin Journal: Neuropharmacology Date: 2013-05-18 Impact factor: 5.250
Authors: Li Wei; Tsung-Ta Liu; Hsiu-Huan Wang; Hui-Mei Hong; Alice L Yu; Hsiang-Pu Feng; Wen-Wei Chang Journal: Breast Cancer Res Date: 2011-10-24 Impact factor: 6.466
Authors: Florian A Siebzehnrubl; Daniel J Silver; Bugra Tugertimur; Loic P Deleyrolle; Dorit Siebzehnrubl; Matthew R Sarkisian; Kelly G Devers; Antony T Yachnis; Marius D Kupper; Daniel Neal; Nancy H Nabilsi; Michael P Kladde; Oleg Suslov; Simone Brabletz; Thomas Brabletz; Brent A Reynolds; Dennis A Steindler Journal: EMBO Mol Med Date: 2013-07-01 Impact factor: 12.137
Authors: Collin M Labak; Paul Y Wang; Rishab Arora; Maheedhara R Guda; Swapna Asuthkar; Andrew J Tsung; Kiran K Velpula Journal: Am J Cancer Res Date: 2016-08-01 Impact factor: 6.166